جست‌وجوی استاد و پژوهشگر

David Alldredمشاهده پروفایل

استاد

• Medicines Optimisation
• Patient Safety
• Deprescribing
• +۵ مورد دیگر

Professor David Alldred is a Professor of Medicines Use and Safety at the University of Leeds' School of Healthcare, within the Faculty of Medicine and Health. His expertise spans medicines optimisation, patient safety, deprescribing, and care home medication management. He leads key research initiatives such as the NIHR Yorkshire and Humber Patient Safety Research Collaboration's 'Decluttering Safely for Safety' theme and co-leads the School of Healthcare's Quality and Safety research theme. Education: PhD (clinical research on care home medication review), MSc in Clinical Pharmacy, PGCert in Learning and Teaching, and BPharm (Hons). Professional memberships include Fellowships of the Royal Pharmaceutical Society and the Higher Education Academy. Research focuses on improving medication use for older adults in care homes and underserved populations, employing systematic reviews, qualitative studies, and RCTs. Notable projects include the CHUMS study (Department of Health-funded medication error analysis in care homes) and leadership roles in NIHR Programme Grants like CHIPPS and CHARMER. He collaborates with NHS England to implement medicines optimisation programs and co-designed multilingual medication review resources to reduce health inequalities. Awards include the Pharmacy Practice UK Research Award (2015) and NIHR Senior Investigator status (2025). His work emphasizes translating evidence into clinical practice, with over 150 publications and supervising NIHR-funded doctoral students in critical care, diabetes, cystic fibrosis, and geriatrics. Led the Care Homes' Use of Medicines Study (CHUMS), contributed to NICE guidelines for care home medicines management, and developed interventions like the Medicines at Transitions Intervention (MaTI) for heart failure patients. His research themes address polypharmacy reduction, medication safety across care transitions, and pharmacist-led deprescribing strategies.

• Sepsis
• Infectious Diseases
• Critical Care Medicine
• +۳ مورد دیگر

Dr. Justin Belsky is an Assistant Professor of Emergency Medicine at Yale School of Medicine, serving as the COVID-19 Safety Officer and Co-Director of Resident Research in Emergency Medicine. He holds an MD from Wayne State University School of Medicine (2011) and an MPH from Harvard School of Public Health (2016). His research focuses on sepsis diagnosis and treatment, including biomarkers, clinical trials, and risk stratification tools. He led the Yale site for the VICTAS trial evaluating vitamin C, thiamine, and hydrocortisone in septic shock. Dr. Belsky directs the Yale Emergency Medicine Specimen Biobank, collecting samples from critically ill patients for future research. His awards include the Partners in Excellence Team Award (2016) and an Outstanding Poster Award (2015). He is actively involved in resident research training and clinical guideline adherence studies. Education: MD: Wayne State University School of Medicine (2011) Emergency Medicine Residency: Henry Ford Hospital (2014) Research Fellowship: Massachusetts General Hospital (2016) MPH: Harvard School of Public Health (2016) Research Interests: Early sepsis identification and treatment Biomarker development for critical illness Fluid management strategies in septic shock Micronutrient therapies in sepsis Emergency department quality improvement Recent Work Focus: Fluid resuscitation protocols and guideline adherence Long-term outcomes of sepsis therapies Actin cytoskeleton as a sepsis biomarker Antibiotic timing in sepsis Awards: 2016: Sepsis Care Redesign, Partners in Excellence Team Award 2015: Outstanding Poster Award (Shock Symposium) Grants & Mentorship: Principal investigator for CLOVERS trial (fluid management in sepsis) Co-Director of Yale’s Emergency Medicine Research Training Program Leadership in resident research mentorship and biobank initiatives

• Multiple Myeloma
• Lymphoma
• Thalassemia
• +۵ مورد دیگر

Professor Joy Ho is a Clinical Professor of Medicine at the University of Sydney’s Central Clinical School and a Senior Staff Specialist in Haematology at Royal Prince Alfred Hospital (RPAH). She serves as Director of Research and Head of the Multiple Myeloma Research Unit and Thalassemia/Haemoglobinopathy Unit at the Institute of Haematology, RPAH. Her research focuses on multiple myeloma, lymphoma, thalassemia, and iron metabolism, with a strong emphasis on clinical trials and translational medicine. She has led numerous multi-centre trials, including pioneering studies on CAR-T cell therapy for lymphoma and novel therapies for myeloma. Prof Ho’s education includes MB.BS. (Hons) from Sydney, D.Phil (Oxford), and fellowships from the Royal Australasian College of Physicians (RACP) and Royal College of Pathologists of Australasia (RCPA). She has held leadership roles in major hematology organizations, including the International Myeloma Working Group (IMWG) and the American Society of Hematology (ASH). Her international collaborations span Singapore, Thailand, and the United States. Her research interests include: Multiple Myeloma: Developing therapies targeting tumor microenvironment and immune modulation. Lymphoma: Pioneering CAR-T cell therapy in Australia. Thalassemia: Gene therapy and iron chelation advancements, including the landmark Northstar trial. Iron Metabolism: Investigating hepcidin and its role in transfusion-dependent anemias. Her recent publications highlight breakthroughs in CAR-T efficacy, myeloma biomarkers, and thalassemia management. Awards include the 2019 Sydney Local Health District Clinical Trial Award and election to the International Myeloma Society Board. She has secured over $2 million in grants for cutting-edge equipment and research. Prof Ho’s academic contributions extend to teaching and supervision, training fellows for RACP/RCPA certifications. Her leadership in national registries (e.g., Australian Haemoglobinopathy Registry) and guidelines (e.g., iron chelation protocols) underscores her commitment to advancing hematology care globally.

• Medical Law
• Law and Natural Sciences Interface
• Legal Causation
• +۳ مورد دیگر

Lena Wahlberg is an Associate Professor and Senior Lecturer at the Department of Law, Lund University, serving as Assistant Head of Department. Her roles include interdisciplinary research and teaching in medical law, evidence law, and jurisprudence. She leads the Law, Evidence and Cognition (LEVIC) research group and participates in the Science and Proven Experience (VBE) program funded by the Swedish Foundation for Humanities and Social Sciences. Her research focuses on legal causation, expert evidence evaluation, and the intersection of law with natural sciences/medicine. Notable projects include analyzing expert testimony reliability, legal implications of scientific evidence gaps, and defining 'science and proven experience' in healthcare decision-making. Recent publications (2024-2025) emphasize healthcare policy, data governance, and legislative reform in abortion laws and research ethics. She collaborates internationally with institutions like Harvard Medical School and Carnegie Mellon University. Teaching responsibilities include coordinating the doctoral course Theoretical Foundations for Doctoral Studies in Law . Supervised doctoral students include Amanda Bills (Public International Law) and Yana Litins’ka (Medical Law). Research funding includes projects from the Swedish Research Council and Riksbankens Jubilieumsfond. Key affiliations: Member of the VBE research consortium (2015-2020+), LEVIC group, and contributor to national policy consultations on health data and medical ethics.

Bertram Müller-Myhsokمشاهده پروفایل

استاد پژوهشی

• Psychiatric Genetics
• Statistical Genetics
• Transcriptomics
• +۳ مورد دیگر

Bertram Müller-Myhsok is a Research Professor and Research Group Leader at the Max Planck Institute of Psychiatry in Munich, Germany. His research focuses on statistical genetics and transcriptomic data analysis in psychiatric disorders, particularly major depression, PTSD, schizophrenia, and their treatment responses. He integrates machine learning with genetic and clinical data to develop predictive models and stratified treatment approaches. Professional activities include leadership roles in the International Max Planck Research School for Translational Psychiatry and collaborations with institutions like the Institut du Cerveau (Paris) and Bernhard Nocht Institute (Hamburg). His work spans genetic epidemiology, psychiatric genomics, and precision medicine, with over 400 publications in high-impact journals. Key research areas include identifying genetic risk factors for mental disorders, developing polygenic scores, and leveraging omics data to uncover disease mechanisms. He leads projects like Psych-STRATA, a Horizon Europe-funded initiative advancing personalized psychiatry through pharmacogenomics.

Veronica Bordes Edgarمشاهده پروفایل

استاد

• Pediatric Neuropsychology
• Neurodevelopmental Disorders
• Bilingual Neuropsychology
• +۴ مورد دیگر

Veronica Bordes Edgar is a Professor in Psychiatry and Pediatrics at UT Southwestern Medical Center. She holds dual roles as co-Director of the Division of Developmental-Behavioral Pediatrics and Director of Clinical Training for the Doctoral Program in Clinical Neuropsychology. Her academic journey includes a PhD in counseling psychology from Arizona State University, clinical training at Harvard Medical School, and a postdoctoral fellowship in neuropsychology at the University of Minnesota. Dr. Edgar specializes in pediatric neuropsychology, focusing on neurodevelopmental disorders (both acquired and genetic) and cultural/bilingual neuropsychological assessment. She is board certified in Clinical Neuropsychology and Pediatric Neuropsychology, and currently serves as President of the American Board of Clinical Neuropsychology. Her research emphasizes culturally competent assessment practices, neurodevelopmental disorder interventions, and the application of teleneuropsychology. Notable contributions include studies on autism spectrum disorder, ADHD caregiver burden, and genetic syndromes like CLN7 and aspartylglucosaminuria.

• Mechanobiology
• Ophthalmology
• Biomedical Engineering
• +۴ مورد دیگر

Darryl Overby is a Professor of Mechanobiology in the Department of Bioengineering at Imperial College London's Faculty of Engineering. His academic affiliations include the CRUK Convergence Science Centre, Cancer Technology Network, and multiple interdisciplinary networks focused on ocular biomechanics, vascular science, and regenerative medicine. He holds an Orcid identifier (0000-0001-9894-7515) and was previously affiliated with Tulane University and Harvard Medical School. Education: Ph.D. in Mechanical Engineering (2002) from MIT under Prof. Roger Kamm, followed by postdoctoral research at Harvard Medical School under Prof. Donald Ingber. His work focuses on cellular biomechanics, mechanotransduction, and the role of mechanical forces in intraocular pressure regulation and glaucoma pathophysiology. Research interests span mechanobiology of Schlemm’s canal endothelial cells, nitric oxide signaling in ocular tissues, and development of organ-on-chip models for studying aqueous humor outflow dynamics. His lab explores how mechanical signals drive transcellular pore formation and how these mechanisms fail in glaucomatous conditions. Key contributions include consensus guidelines for Brillouin microscopy measurements, ex vivo perfusion studies, and the role of TRPV4 channels in mechanosensing. His work integrates engineering techniques with clinical ophthalmology to advance therapies targeting glaucoma and ocular hypertension. Professional activities include leadership roles in the Ocular Biomechanics Network and Wound Healing and Regeneration Network. His research has led to patents for devices enhancing aqueous humor drainage and RNAi-based therapies.

Jeffrey T. Jensenمشاهده پروفایل

استاد

• Contraception
• Reproductive Health
• Translational Research
• +۲ مورد دیگر

Jeffrey T. Jensen, M.D., M.P.H., is the Leon Speroff Professor and Vice Chair for Research in the Department of Obstetrics and Gynecology at Oregon Health & Science University (OHSU). He holds joint appointments as Professor of Public Health and Preventive Medicine and serves as a Core Scientist at the Oregon National Primate Research Center (ONPRC). Dr. Jensen completed his medical degree at Emory University, a Master of Public Health at the University of Washington, and residency training at OHSU. Research Focus: Dr. Jensen leads translational and clinical research programs focused on contraceptive innovation. His work emphasizes nonhuman primate models to develop: Novel contraceptive agents targeting oocyte-specific pathways Non-surgical permanent contraception methods Optimized emergency contraception for diverse populations He directs OHSU's Women’s Health Research Unit and the Gates Foundation-funded Oregon Permanent Contraception Research Center (OPERM). Recent Publications: His 15 most recent articles (2023-2025) demonstrate concentrated expertise in: Advanced hormonal contraceptive formulations (IUDs, vaginal rings, oral agents) Weight-adjusted dosing strategies for emergency contraception Biomarker validation for contraceptive efficacy monitoring Real-world assessment of bleeding pattern management Leadership & Collaboration: Dr. Jensen is Principal Investigator of the NICHD Contraception Clinical Trials Network and collaborates with global health organizations (CONRAD, FHI360, Population Council). He serves as Deputy Editor for the journal Contraception and consults for multiple pharmaceutical companies on product development.

Vitaly Kheyfetsمشاهده پروفایل

دانشیار

• Pulmonary Arterial Hypertension
• Critical Care Medicine
• Pediatric Cardiology
• +۴ مورد دیگر

Vitaly Kheyfets, PhD, serves as Associate Professor in the Department of Pediatrics-Critical Care Medicine at the University of Colorado Anschutz Medical Campus School of Medicine, where he directs research at the intersection of pediatric critical care and cardiopulmonary pathophysiology with emphasis on pulmonary arterial hypertension (PAH). His primary research focuses on right ventricular adaptation to pulmonary hypertension, utilizing machine learning-driven multi-omics analysis to identify disease biomarkers and molecular networks. He pioneers computational fluid dynamics approaches for hemodynamic modeling in congenital heart conditions like Glenn physiology, while also investigating sleep oscillatory patterns as neurodegenerative biomarkers. His methodology integrates proteomics, spatial transcriptomics, and pressure waveform analysis to dissect vascular remodeling mechanisms. Publication trends reveal a strong emphasis on translating computational models into clinical applications for PAH prognostication, with recent work developing AI-cooperative diagnostic platforms and characterizing microvascular changes in the right ventricle. Cross-disciplinary collaborations span proteomics, imaging, and sleep neuroscience, demonstrating consistent innovation in both pulmonary hypertension and neurodegenerative disease biomarker discovery.

Christine Clarkمشاهده پروفایل

استادیار

• Otolaryngology
• Laryngology
• Voice Disorders
• +۵ مورد دیگر

Christine Clark, MD, MSc is an attending laryngologist at Weill Cornell Medicine’s Sean Parker Institute for the Voice and Assistant Professor in the Department of Otolaryngology-Head and Neck Surgery at Weill Cornell Medical College. She earned her B.A. from the University of Pittsburgh (2011) and her M.D. from Pennsylvania State University College of Medicine (2017), followed by residency at Georgetown University Medical Center and a fellowship in Laryngology at Weill Cornell, where she also obtained a master’s degree in Clinical and Translational Science. B.A. - University of Pittsburgh (2011) M.D. - Pennsylvania State University College of Medicine (2017) Residency - Georgetown University Medical Center Fellowship - Sean Parker Institute for the Voice (Laryngology) Master’s - Clinical and Translational Science at Weill Cornell Dr. Clark specializes in evaluating and treating swallowing, voice, and airway disorders. Her research focuses on chronic cough, laryngeal hypersensitivity, and benign phonotraumatic vocal fold lesions. She has developed clinical tools like the 3D-printed injection laryngoplasty simulator and quality improvement initiatives for surgical airway management. Her clinical work and research span topics such as vocal fold hemorrhage management, pharyngeal residue quantification in dysphagia, and granuloma as markers of malignancy. Recent publications emphasize global otolaryngology capacity building and performer-specific voice injury care. Scientific awards include: Teaching awards for excellence in medical student education during residency Dr. Clark is affiliated with the Sean Parker Institute for the Voice at Weill Cornell Medicine and serves as an Assistant Professor of Otolaryngology.

• Healthy Ageing
• Pharmacology
• Pharmacoepidemiology
• +۳ مورد دیگر

Dr. Kenji Fujita is a Research Fellow at the Kolling Institute, University of Sydney, specializing in ageing, pharmacology, and pharmaceutical care quality. He holds a PhD, MScMed (ClinEpid), and BPharm from the University of Sydney. Previously a pharmacist in Japan, he leads international initiatives in the Pharmaceutical Care Network Europe (PCNE) and the International Pharmaceutical Federation (FIP). His work focuses on deprescribing strategies, polypharmacy, and developing quality indicators for healthcare services. Dr. Fujita’s research integrates big data analysis, statistical modeling, and machine learning to address challenges in geriatric pharmacotherapy. Current projects include validating frailty indices, evaluating deprescribing interventions in older adults, and developing NLP tools for clinical documentation analysis. He has also contributed to assessing organizational readiness for guideline implementation in community pharmacies. Awards include the 2023 Outstanding Poster Presentation Award at the IAGG Asia/Oceania Congress and 2022 Best Poster at the Japanese Society of Social Pharmacy. He has secured grants such as the 2024 electronic frailty index project and the 2021 systems-approach to medication review initiative. Dr. Fujita collaborates with global networks like J-HOP (Japan Home Visiting Pharmacy Association) and leads multidisciplinary teams across Australia and Europe. His lab focuses on translating data-driven insights into actionable clinical practices to improve medication safety and quality in ageing populations.

Nora Uglik-Maruchaمشاهده پروفایل

پژوهشگر ارشد

• Autism in women
• Psychometrics
• Questionnaire development
• +۴ مورد دیگر

Nora Uglik-Marucha is an NIHR Doctoral Research Fellow at King’s College London’s Department of Biostatistics & Health Informatics, affiliated with the Institute of Psychiatry, Psychology & Neuroscience. Her work focuses on autism in women and misophonia through advanced psychometric methodologies. She holds MSc and BSc degrees in Clinical Neuropsychiatry and Psychology from King’s College London. Research interests include gender bias in autism screening tools, measurement invariance analysis, and questionnaire development. Her doctoral project develops novel autism assessment tools for women under Dr. Silia Vitoratou and Prof. Francesca Happé. Key contributions include the S-Five tool for misophonia assessment and validation studies across cultures. She has published on misophonia mechanisms, cross-cultural measurement robustness, and autism screening equity.

• Geriatric Pharmacology
• Deprescribing
• Pharmacoepidemiology
• +۳ مورد دیگر

Nashwa Masnoon is a Postdoctoral Research Fellow in Geriatric Pharmacotherapy at the Kolling Institute, part of the Faculty of Medicine and Health at the University of Sydney. She is also a hospital pharmacist at the Royal North Shore Hospital. Her academic background includes a BPharm(Hons) and a PhD from the University of South Australia, where her doctoral work focused on identifying risks of adverse outcomes from polypharmacy in older adults with multimorbidity. Dr Masnoon’s research interests span geriatric pharmacology, deprescribing practices, pharmacoepidemiology, and quality use of medicines. Her current projects include developing stewardship programs for anticholinergic/sedative deprescribing, optimizing medication use in hospitals for older patients, and educating hospital pharmacists using the Drug Burden Index intervention bundle. She has co-supervised Honours students in 2022 and 2023, focusing on deprescribing in hospital settings and patient-reported experiences post-intervention. Research Themes: Healthy Ageing Key Approaches: Systematic reviews, clinical interventions, pharmacoepidemiological analysis Dr Masnoon has received notable awards including the 2023 FMH Showcase Travel Award, Royal North Shore Hospital Travel Fellowship (2023), and a 2017 People’s Choice Award for her 3 Minute Thesis presentation. Her work emphasizes improving medication outcomes through evidence-based deprescribing and precision medicine approaches. She is affiliated with the Australasian Pharmaceutical Science Association (APSA), International Pharmaceutical Federation (FIP), and Australian Deprescribing Network (ADeN). Her grants include the 2024 electronic frailty index project and a 2022 travel award-funded initiative.

Lauren Cirrincioneمشاهده پروفایل

دانشیار

• Infectious Diseases
• Mechanisms of Drug Interactions
• Pharmacokinetics-Pharmacodynamics
• +۵ مورد دیگر

Dr. Lauren Cirrincione is an Associate Professor in the Department of Pharmacy at the University of Washington School of Pharmacy in Seattle, Washington. Her academic appointment is within the Department of Pharmacy, which is part of the School of Pharmacy at the University of Washington. Dr. Cirrincione earned her Doctor of Pharmacy (PharmD) degree from the University of Pittsburgh School of Pharmacy and a Master of Public Health (MPH) in epidemiology from the University of Nebraska Medical Center. She completed a clinical pharmacology fellowship in HIV at the University of Nebraska Medical Center. Dr. Cirrincione's research program addresses mechanisms of hormone-mediated drug interactions, with a primary focus on clinical, translational pharmacology in transgender medicine. Her expertise spans Infectious Diseases, Mechanisms of Drug Interactions, Pharmacokinetics-Pharmacodynamics, Transgender and Gender Diverse Research, and Translational Research. Her work examines how gender-affirming hormone therapy interacts with other medications, particularly antiretrovirals, and investigates the clinical implications of these interactions for transgender patients. She has made significant contributions to understanding estradiol concentrations in gender-affirming therapy, kidney function assessment in gender-diverse populations, and the inclusion of transgender individuals in clinical trials. Her publications demonstrate a consistent focus on improving pharmacological care for transgender and gender-diverse individuals, with recent work examining adolescent transgender medicine, psychotropic medication interactions, and self-injection experiences among transgender people on hormone therapy. Her research bridges clinical pharmacology with gender-affirming care, addressing critical gaps in evidence-based practice for this population. Dr. Cirrincione teaches PHRMCY 535: Pharmacotherapeutics V at the University of Washington School of Pharmacy. Her scientific contributions have advanced the field of transgender pharmacology, with particular emphasis on clinical applications and evidence-based approaches to medication management for transgender patients.

Adam C Steinمشاهده پروفایل

دانشیار

• Gastroenterology
• Hepatology
• Inflammatory Bowel Disease
• +۵ مورد دیگر

Adam C Stein is an Associate Professor in the Department of Medicine at Northwestern University's Feinberg School of Medicine, specializing in gastrointestinal disorders of the small bowel. He provides clinical care at Northwestern Memorial Hospital and Ann & Robert H. Lurie Children's Hospital of Chicago, with expertise in Crohn's disease, celiac disease, intestinal failure, and malnutrition management. Education: MD from University of Illinois, Chicago (2007) Residency in Internal Medicine at University of Chicago (2010) Fellowship in Gastroenterology at University of Chicago (2013) Fellowship in Nutrition at University of Chicago (2014) Dr. Stein's research focuses on small bowel pathologies including obscure gastrointestinal bleeding, cystic fibrosis-related GI complications, and advanced endoscopic techniques like video capsule endoscopy and double balloon enteroscopy. His clinical work emphasizes nutritional support through parenteral nutrition and tube feeding for complex malabsorption syndromes. Recent publications (2022-2024) demonstrate concentrated research on gastrointestinal manifestations in rare diseases (nephropathic cystinosis) and cystic fibrosis, with particular attention to nutritional management barriers and drug safety profiles in inflammatory bowel disease therapies. No scientific awards are listed in the current profile. Information regarding student advising and research grants is not specified in available materials, though Dr. Stein maintains active industry collaborations through consulting roles with AbbVie, Amgen, and Takeda Pharmaceuticals. As a member of the Division of Gastroenterology and Hepatology, Dr. Stein collaborates with multidisciplinary teams across Northwestern Medicine's academic hospitals, contributing to clinical committees including the ACG Training Committee (2017-2023) and editorial boards such as Current Gastroenterology Reports (2019-2023).